CDKN2A and chronic kidney disease: Metformin treatment for 72 h attenuated the expression of LMNA gene and prelamin A and DDR signaling as well as the senescent features of CKD ADMSCs, including upregulated CDKN2A expression and SASP (Figure 5b,d–f).